After annual revenue grew 3.6%, Amdocs forecasts a 14.3%-17.9% decline in fiscal 2027.
Amdocs reported fiscal 2026 revenue of $4.7B, up 3.6%, and Q4 revenue of $1.2B, up 3.8%. GAAP EPS was $4.68, down 7.3%, while non-GAAP EPS was $7.41, up 6.0%. The company forecasts a 14.3%-17.9% revenue decline in fiscal 2027 due to T-Mobile disputes and other headwinds. Amdocs announced new strategic deals and an acquisition in the insurance sector.
How this was made
The 30-second read
Why it matters
The guidance downgrade and T‑Mobile dispute are likely to depress the share price in the short term, while the announced strategic agreements could provide longer‑term upside.
Market read
Amdocs' guidance cut and litigation risk are the primary drivers for near‑term price action.
What to watch
Potential upside from the insurance platform acquisition and multi‑year AT&T contract.
Background
Amdocs released its FY2026 financials and forward outlook, highlighting both operational successes and emerging headwinds.
Ticker impact
Amdocs reported FY2026 results and issued new FY2027 guidance forecasting a 14.3%-17.9% revenue decline, plus disclosed a litigation dispute with T‑Mobile and announced strategic agreements and an insurance‑platform acquisition.
downward pressure as investors price in lower revenue outlook and potential loss of T‑Mobile business.
Revenue guidance cut and a major customer dispute are material catalysts that typically trigger sell‑side activity.
Market effects
Telco software providers may face heightened scrutiny of customer concentration risks.
North American telecom software segment could see modest pullback.
Limited to Amdocs and peers; no broad market shift expected.
Counterpoint
If the new aOS deals translate into higher margins, the guidance cut may be temporary.
Key entities
- companyAmdocs Limited
Software and services provider to telecom operators.
- companyT‑Mobile
Major U.S. wireless carrier and Amdocs customer.
- companyAT&T
Largest U.S. telecom, new strategic aOS agreement.